The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
about
Beta-blockers for congestive heart failure in childrenPredictors of disease progression in pediatric dilated cardiomyopathy.Dysregulation of cardiolipin biosynthesis in pediatric heart failure.Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy.Pediatric heart failure: current state and future possibilities.The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy.Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.miRNA expression in pediatric failing human heart.β-Adrenergic receptor antagonism in mice: a model for pediatric heart disease.Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.Inflammatory cytokines, apoptotic, tissue injury and remodeling biomarkers in children with congenital heart disease.Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.National prescribing trends for heart failure medications in children.Paediatric heart transplantation in Australia comes of age: 21 years of experience in a national centre.Clinical and Molecular Comparison of Pediatric and Adult Reverse Remodeling With Ventricular Assist Devices.Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.Pediatric dilated cardiomyopathy hearts display a unique gene expression profile.Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.Exosomes from pediatric dilated cardiomyopathy patients modulate a pathological response in cardiomyocytes.Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy.Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.Pediatric Cardiomyopathies.
P2860
Q24186346-E176F2A5-A33D-4B66-945D-131C9DD075CFQ33952576-D40D92ED-1E61-4DC2-B4AF-B050A458C9E5Q33969031-8044D467-B2C5-43A2-AC64-BA7CE072738FQ35002036-C3C1C113-3902-42D6-B337-4C858BDD0404Q35028584-A60D52D5-6CE8-49F5-8660-7D38C6B40A13Q35032826-4CF808D9-8711-4E9A-8A40-568F48B3E8FBQ35609793-3B7D075A-B85A-4B85-A842-44CA25256EF4Q36011037-94A14F4E-1577-410A-8279-1DC48C495C1DQ36435963-54C9F6BE-880C-4B6B-AD17-B3A4A6CC4B36Q36959812-A1A06E78-AC66-49DA-91B8-E29B30C1486FQ37235097-0C8599E8-9044-4935-94BB-7CB262353A38Q37423781-2D908BE1-D75E-471C-BD5E-C7FE93293ADDQ37709115-5F3D53A0-9C80-4A1C-A07B-4626118E88FCQ37742299-6FC1E852-AD5C-43D6-B054-15571643FDC0Q38204017-0E46EC18-3EA4-4BB2-92AF-D8B4CFF53039Q38244452-9330C377-BB46-49CB-97F4-B1FADF635153Q38417459-52E64EF5-4F21-496A-9E92-1608B27416D9Q41068150-058B431F-CA87-4410-9D55-2F7C5C8E1428Q41068198-660C6D46-2446-49AD-96B2-EE4F88111F71Q41700883-23935571-327D-4FB5-B245-04E75843332AQ42950227-4D60A0A6-F5D0-473B-8B7A-32B7E4CE503DQ46233514-67156CD9-7324-4199-B220-21305D66C4A7Q48302617-8F61F5D5-FFA8-4005-9B60-C3F42D54FB61Q48410009-E0062146-E433-46D2-9474-504035DDF583Q50542706-CB32420E-85A1-4A11-9294-A059BB81BBF1Q51352445-39773CB8-6B58-4105-9B2A-2FC80CF13229
P2860
The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of changing medical ...... iatric dilated cardiomyopathy.
@en
The impact of changing medical ...... iatric dilated cardiomyopathy.
@nl
type
label
The impact of changing medical ...... iatric dilated cardiomyopathy.
@en
The impact of changing medical ...... iatric dilated cardiomyopathy.
@nl
prefLabel
The impact of changing medical ...... iatric dilated cardiomyopathy.
@en
The impact of changing medical ...... iatric dilated cardiomyopathy.
@nl
P2093
P1476
The impact of changing medical ...... iatric dilated cardiomyopathy.
@en
P2093
Andrew N Redington
Anne I Dipchand
Jonathan R Abraham
Lee N Benson
Paul F Kantor
P304
P356
10.1016/J.JACC.2009.11.059
P407
P577
2010-03-01T00:00:00Z